Safety, Tolerability and Immune Effects of the Nasal Foralumab in Healthy Human Volunteers
Clinical trial NCT06879067 · COMPLETED
Trial details
- NCT number
- NCT06879067
- Sponsor
- Tiziana Life Sciences LTD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-12
- Primary completion
- 2019-07-23
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.